Xtrackers MSCI World Biotechnology UCITS ETF (LON:XGES)

Assets	8.59M
Expense Ratio	0.35%
PE Ratio	27.65
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	+45.57%

Volume	195
Open	3,328.50
Previous Close	3,294.00
Day's Range	3,295.66 - 3,329.50
52-Week Low	2,244.25
52-Week High	3,349.50
Beta	n/a
Holdings	124
Inception Date	Jul 12, 2022

About XGES

Xtrackers MSCI World Biotechnology UCITS ETF is headquartered in Frankfurt am Main, Hessen, Germany.

• Asset Class: Equity
• Category: Theme
• Stock Exchange: London Stock Exchange
• Ticker Symbol: XGES
• Provider: Xtrackers
• Index Tracked: MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 Index - Benchmark TR Net

Performance

XGES had a total return of 45.57% in the past year, including dividends. Since the fund's inception, the average annual return has been 4.47%.

Top 10 Holdings

46.41% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	8.27%
Natera, Inc.	NTRA	5.47%
Illumina, Inc.	ILMN	5.02%
Agilent Technologies, Inc.	A	4.62%
Danaher Corporation	DHR	4.25%
Vertex Pharmaceuticals Incorporated	VRTX	4.17%
Lonza Group AG	LONN	3.85%
argenx SE	ARGX	3.77%
Guardant Health, Inc.	GH	3.52%
Insmed Incorporated	INSM	3.48%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error